| 000 | 01867cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030906.0 | ||
| 008 | 131123s2013 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.33.Ph.D.2013.Ha.C | ||
| 100 | 0 | _aHaytham Abdallah Katamish | |
| 245 | 1 | 0 |
_aComparative study between endoscopic band ligation versus propranolol versus carvedilol for primary prophylaxis of variceal bleeding / _cHaytham Abdallah Katamish ; Supervised Ayman Yousry Abdelraheem , Rabab Fouad Emam , Moataz Serry Syam |
| 246 | 1 | 5 | _aمقارنة بين ربط دوالى المرئ وعقار البروبرانولول وعقار الكارفيديلول فى الوقاية الاولية من نزيف دوالى المرئ |
| 260 |
_aCairo : _bHaytham Abdallah Katamish , _c2013 |
||
| 300 |
_a172 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine | ||
| 520 | _aPortal hypertension is one of the most significant complications of both acute and chronic liver diseases. it generally develops as a result of an increase in vascular resistance at the pre-hepatic, intra-hepatic, or post-hepatic level. An increase in portal blood flow may also contribute. The dominat cause of portal hypertension relates to liver cirrhosis which increase resistance through the hepatic sinusoid | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAlkaline phosphatase | |
| 653 | 4 | _aEndothelin | |
| 653 | 4 | _aHemoglobin | |
| 700 | 0 |
_aAyman Yousry Abdelraheem , _eSupervisor |
|
| 700 | 0 |
_aMoataz Serry Syam , _eSupervisor |
|
| 700 | 0 |
_aRabab Fouad Emam , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAml _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44149 _d44149 |
||